British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

An observational study recommended by NICE, monitoring the long-term safety of biologic treatments for psoriasis.
Since 2007, over 20,000 patients have been registered across 160+ hospitals, with more than 110,000 follow-ups recorded.

Quick links

Access the Patient Portal

BADBIR participants can visit the Patient Portal to complete questionnaires.

Opens in new window

Log in to the BADBIR database

Clinicians can gain access to the BADBIR database.

Opens in new window

Check the documentation for study site files

Ensure your site file is up-to-date and check you’re using our latest CRFs.

Explore the site

Participants

Information for psoriasis treatment patients participating in the BADBIR study.

Clinicians

Resources for clinicians involved in the BADBIR study. 

 

R&D

Explore our site file documents and find out about study payments and Clinical Research Networks.

Data and publications

Explore publications and learn how to access data.

News

Stay up-to-date with the latest BADBIR study news.